Intraoperative NOL Titration
Study Details
Study Description
Brief Summary
To demonstrate that intraoperative NOL-guided titration of fentanyl improves initial recovery characteristics.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Detailed Description
Previous work has shown that NOL accurately quantifies nociception during general anesthesia.6 Presumably, titrating opioids to NOL will therefore provide individual guidance so that patients will be given about the right amount. Patient given the right amount will presumably awaken quickly when anesthesia is done, and have good initial pain control in the PACU. To the extent that NOL titration facilitates optimal opioid dosing, patients are likely to have better PACU experiences - which would be an important outcome that clinicians and regulators are likely to take seriously.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Control Group Clinicians will be blinded to PMD-200 NOL monitoring and use clinical judgement to determine how much fentanyl should be given, and when. |
Device: PMD-200 Nol-guided opioid administration
PMD-200 NOL values exceeding 25 for more than 30 seconds will typically be treated with boluses of fentanyl 1µg/kg ABW, up to a maximum of 100 µg per boluses, 5-minute intervals. Towards the end of the surgery (approximately 30-45 minutes before end of surgery, based on clinical judgment), the boluses of fentanyl will be reduced to 0.5 µg/kg ABW, up to a maximum of 50 µg per boluses, 5 minutes intervals. The target of a PMD-200 NOL score below 25 will be maintained until surgery ends
Other Names:
|
Active Comparator: PMD-200 NOL group Clinicians will titrate fentanyl to keep PMD-200 NOL under 25 - always using good clinical judgement for individual patients |
Drug: Routine opioid management
Clinical judgement will be according to their standard practice and may include interpretation of blood pressure, heart rate, diaphoresis, tearing, and pupil size. Boluses of fentanyl 1 µg/kg actual body weight (ABW), up to a maximum dose of 100 µg per bolus, can be given per clinical judgement.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Pain Scores [60 minutes]
The investigators will evaluate the pain scores at 10-minute using pain scores (0-10 verbal response scale)
Secondary Outcome Measures
- Pain Scores <5. [60 minutes]
The investigators will evaluate whether or not the pain score at any measured interval is < 5, using (0-10 verbal response scale)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Adults having major non-cardiac surgery expected to last ≥2 hours
-
American Society of Anesthesiologists physical status 1-3
-
Age 21-85 years old
-
Planned endotracheal intubation
Exclusion Criteria:
-
Planned neuraxial or regional block
-
Clinician preference for an opioid other than, or in addition to, fentanyl
-
Non-sinus heart
-
Neurologic condition that, in the opinion of the investigators, may preclude accurate assessment of postoperative pain and nausea
-
Lack of English language fluency
-
Routine user of psychoactive drugs other than opioids
-
Contraindication to sevoflurane, fentanyl, morphine, or ondansetron.
-
Intracranial surgery.
-
BMI > 40
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cleveland Clinic | Cleveland | Ohio | United States | 44195 |
Sponsors and Collaborators
- The Cleveland Clinic
Investigators
- Principal Investigator: Kurt Ruetzler, MD, The Cleveland Clinic
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 19-1646